Robert ANCUCEANU, UMF Carol Davila, Bucharest, Romania
Conference Title: WHATEVER IS IN A NAME, IT SHOULD BE STANDARDIZED – A FORMAL ANALYSIS OF THE ACTIVE SUBSTANCES IN THE HUMAN MRIndex
Robert Ancuceanu PhD is a professor within the Bucharest Faculty of Pharmacy (Carol Davila University of Medicine and Pharmacy), where he teaches Cell and Molecular Biology and Pharmaceutical Botany and is currently a vice-dean. With a PhD in pharmacy, a master in biostatistics and a BSc in law, he has worked in different pharmaceutical domains, from academic to industrial and regulatory. He was director general of the General Directorate for Pharmaceutics and Medical Devices within the Romanian Ministry of Health and Vice-president of the Romanian National Medicines Agency. He was a member of the EMA Committee for Human Medicinal Products (CHMP), of the Paediatric Committee (PDCO) and an alternate member of the Committee on Herbal Medicinal Products (HMPC), as well as a member in several committees and working groups in the pharmaceutical field at national level. He is a Steering group member of the TOPRA Product information and Labelling SPIN. He has published 47 scientific papers, two books as a single author and was a co-author or chapter author to 13 books. Besides his broad interest for all aspects of the pharmaceutical domain, Robert considers himself a late Renaissance man, having also interests in law, history, music, biostatistics, programming and computer science, sociology, art and literature.
Rita AMBRUS, University of Szeged, Szeged, Hungary
Conference Title: USING NANOSUSPENSION IN TRADITIONAL AND ALTERNATIVE DRUG FORMULATION
Rita Ambrus PhD is an Associate Professor in Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged. Professor Ambrus is also an experimental leader of Nanotechnological Research group of Interdisciplinary Excellence Centre University of Szeged. In her research group development of technological procedures (nano- and microparticle production) and alternative drug administration (pulmonal and intranasal) could be found -to reach improved bioavailability of poorly water-soluble drugs. Prof. Ambrus published more than 100 scientific paper (cumulated impact factor: 173,7; independent citation: 504, Hirsch index: 16). The number of her international cooperation is 11. She was/is a supervisor by 11 PhD works and 15 diplomworks.
Sharareh SALAR-BEHZADI, Research Center Pharmaceutical Engineering (RCPE) , Graz, Austria
Conference Title: THE FUNCTIONALITY OF LIPID-BASED EXCIPIENTS
Sharareh Salar-Behzadi held her diploma in Pharmacy and PhD in Pharmaceutical Technology from University of Vienna, Austria. Her experience covers a broad range, including formulation and process development for production of solid dosage forms. She works as Principal Scientist at Research Center Pharmaceutical Engineering (RCPE) GmbH (Graz Austria) since 2012 and as lecturer at Department of Pharmaceutical Technology and Biopharmacy, University of Graz. An important research focus of her is the development of patient-centric pharmaceutical products with advanced stability, based on lipid-based excipients.
Adiana MARCOVICI, Terapia SA – A SUN Pharma Company, Cluj-Napoca, Romania
Conference Title: THE BIOEQUIVALENCE STUDY DESIGN OF HIGH VARIABLE DRUGS
Adriana MARCOVICI PhD has over 20 years experience in the pharmaceutical industry of generic drugs, especially in the field of clinical bioequivalence studies. At Terapia SA, a Sun Pharma company, Dr. Marcovici coordinates the activity of an experienced group of researchers, doctors, pharmacists, chemists and biologists, specialized in organizing, planning, executing bioequivalence studies, developing and validating bioanalytical methods, pharmacokinetic and statistical analysis.
Zsombor Kristóf Nagy, Budapest University of Technology and Economics, Budapest , Hungary
Conference Title: DEVELOPMENT OF INNOVATIVE CONTINUOUS TECHNOLOGIES FOR THE PHARMACEUTICAL INDUSTRY
Zsombor K. Nagy PhD is an associate professor of pharmaceutical technology at the Department of Organic Chemistry and Technology (Budapest University of Technology and Economics). He is the pharma division head of FirePharma research group. Since 2015 he is an elected board member of Crystallization and Pharmaceutical Technology section of the Hungarian Chemical Society. His main research interests are continuous pharmaceutical manufacturing, dissolution enhancement using amorphous solid dispersions, electrospinning and process analytical technology. He has published about 90 peer-reviewed scientific papers (citations: >1700).
Andreea Letitia ARSENE, UMF Carol Davila, Bucharest, Romania
Conference Title: BUILDING MICROBIOLOGICAL QUALITY INTO DRUGS
Andreea Letitia ARSENE, PhD is Professor of Pharmaceutical Microbiology within the University of Medicine and Pharmacy „Carol Davila”, Faculty of Pharmacy, Bucharest, Romania. The PhD and habilitation thesis were defended in the pharmaceutical field together with a master in biotechnologies. She published over 70 scientific papers, authored and co-authored several books and chapter books published abroad and she also holds 9 international prizes. Prof. Arsene is the Secretary of the Romanian Society for Pharmaceutical Sciences and the Editor-in-chief of FARMACIA, the only pharmaceutical scientific journal in Romania, having an impact factor of 1,527/2018 (Web of Science Core Collection, Clarivate Analytics).